Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Small-molecule drug screening identifies drug Ro 31-8220 that reduces toxic phosphorylated tau in Drosophila melanogaster

22 Jun 2019

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Cholinesterase and Neurodegenerative Diseases
Share to Computational Drug Discovery Methods

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 31233882
DOI: 10.1016/j.nbd.2019.104519

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Small-molecule drug screening identifies drug Ro 31-8220 that reduces toxic phosphorylated tau in Drosophila melanogasterPMID 31233882Read ↗

Senolytic and senomorphic secondary metabolites as therapeutic agents in Drosophila melanogaster models of Parkinson’s diseaseSemantic proximity Read ↗

Using Drosophila as a platform for drug discovery from natural products in Parkinson's diseaseSemantic proximity Read ↗

Chemical screening platforms for autophagy drug discovery to identify therapeutic candidates for Huntington's disease and other neurodegenerative disordersSemantic proximity Read ↗

Discovery of Dual Aβ/Tau Inhibitors and Evaluation of Their Therapeutic Effect on a Drosophila Model of Alzheimer’s DiseaseSemantic proximity Read ↗

Natural Compound Boldine Lessens Myotonic Dystrophy Type 1 Phenotypes in DM1 Drosophila Models, Patient-Derived Cell Lines, and HSALR Mice.Semantic proximity Read ↗

Caenorhabditis elegans as an emerging high throughput chronotherapeutic drug screening platform for human neurodegenerative disordersSemantic proximity Read ↗

Integrated computational and <i>Drosophila</i> cancer model platform captures previously unappreciated chemicals perturbing a kinase networkSemantic proximity Read ↗

Identification of potential therapeutic compounds for Parkinson's disease using Drosophila and human cell models.Semantic proximity Read ↗

The Flavonoid Derivative 2-(4′ Benzyloxyphenyl)-3-hydroxy-chromen-4-one Protects Against Aβ42-Induced Neurodegeneration in Transgenic Drosophila: Insights from In Silico and In Vivo StudiesSemantic proximity Read ↗

TOR-Mediated Cell-Cycle Activation Causes Neurodegeneration in a Drosophila Tauopathy ModelSemantic proximity Read ↗

Drosophila as a model system for studying lifespan and neuroprotective activities of plant-derived compoundsSemantic proximity Read ↗

A chemical with proven clinical safety rescues Down-syndrome-related phenotypes in through DYRK1A inhibition.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.